(Q35087590)

6 August 2017

1 reference

title

Microalbuminuria in diabetes: focus on cardiovascular and renal risk reduction (English)

1 reference

6 August 2017

George L Bakris

1

1 reference

6 August 2017

James R Sowers

series ordinal

2

1 reference

6 August 2017

publication date

1 June 2002

1 reference

6 August 2017

published in

Current diabetes report

1 reference

6 August 2017

volume

2

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

258-262

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-002-0092-4

6 August 2017

exact match

0 references

cites work

Diabetes, hypertension, and cardiovascular disease: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0092-4

Insulin resistance in microalbuminuric hypertension. Sites and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0092-4

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0092-4

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0092-4

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-002-0092-4

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

12 December 2020

Diabetes and cardiovascular disease.

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy

1 reference

12 December 2020

Microalbuminuria in essential hypertension and diabetes mellitus

1 reference

12 December 2020

Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs

1 reference

12 December 2020

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

1 reference

12 December 2020

Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation

1 reference

12 December 2020

Renal injury from angiotensin II-mediated hypertension

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial

1 reference

12 December 2020

Microalbuminuria precedes the development of NIDDM

1 reference

12 December 2020

Microalbuminuria: what is it? Why is it important? What should be done about it?

1 reference

12 December 2020

Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria.

1 reference

12 December 2020

Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease

1 reference

12 December 2020

American Diabetes Association: clinical practice recommendations 2002

1 reference

12 December 2020

Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects

1 reference

12 December 2020

Impaired Insulin-Induced Glucose Uptake by Extrahepatic Tissue Is Hallmark of NIDDM Patients Who Have or Will Develop Hypertension and Microalbuminuria

1 reference

12 December 2020

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

1 reference

12 December 2020

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

12 December 2020

Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group

1 reference

12 December 2020

Preservation of renal function: the spectrum of effects by calcium-channel blockers

1 reference

12 December 2020

Microalbuminuria: prognostic implications.

1 reference

12 December 2020

Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy

1 reference

12 December 2020

Abnormal permeability to proteins and glomerular lesions: a meta-analysis of experimental and human studies

1 reference

12 December 2020

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

12 December 2020

10.1007/S11892-002-0092-4

Identifiers

DOI

1 reference

6 August 2017

1 reference